A Peek at Viemed Healthcare's Future Earnings
Viemed Healthcare (NASDAQ:VMD) will release its quarterly earnings report on Wednesday, 2026-03-04. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Viemed Healthcare to report an earnings per share (EPS) of $0.12.
The announcement from Viemed Healthcare is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
The company's EPS missed by $0.01 in the last quarter, leading to a 2.64% drop in the share price on the following day.
Here's a look at Viemed Healthcare's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.10 | 0.06 | 0.10 | |
| EPS Actual | 0.09 | 0.08 | 0.06 | 0.10 |
| Price Change % | -2.64 | 7.91 | -11.69 | 5.41 |
Stock Performance
Shares of Viemed Healthcare were trading at $8.85 as of March 02. Over the last 52-week period, shares are up 16.75%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
All You Need to Know About Viemed Healthcare
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
Financial Insights: Viemed Healthcare
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Viemed Healthcare displayed positive results in 3 months. As of 30 September, 2025, the company achieved a solid revenue growth rate of approximately 23.98%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Viemed Healthcare's net margin excels beyond industry benchmarks, reaching 4.88%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Viemed Healthcare's ROE excels beyond industry benchmarks, reaching 2.57%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Viemed Healthcare's ROA stands out, surpassing industry averages. With an impressive ROA of 1.82%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.18, Viemed Healthcare adopts a prudent financial strategy, indicating a balanced approach to debt management.
To track all earnings releases for Viemed Healthcare visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.